WLF Answers Democrats In First Amendment Off-Label Promotion Debate

Off-label information is not "inherently misleading," and consequently FDA should ease restrictions for disseminating it, the Washington Legal Foundation asserts in its response to congressional Democrats' interpretation of First Amendment case law